Incyte to Report First Quarter Financial Results

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, April 30, 2024.

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13745743.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240411369652/en/

Media
[email protected]

Investors
[email protected]

Source: Incyte

You May Also Be Interested In

• INFRONEER Teams with Accenture to Build New Financial Data and Insights Platform to Advance its Group Management Capabilities in Just Three Months
• Wall Street scrambles to lift Micron price targets ahead of earnings
• LG Display OLED becomes world's first to achieve "Perfect Color/Brightness" certification